Ncardia is a stem cell drug discovery and development company. We believe that human stem cell biology will get better therapies to patients faster. We develop human cellular (disease) biology in optimized assay systems to enable safety and efficacy testing with a better translation into the clinic. Our novel DiscoverHIT Screening Platform enables a flexible solution for bringing human induced pluripotent stem cell (hiPSC) models to drug discovery campaigns. Our Manufacturing Platform generate industry scale hiPSC batches enabling drug screening as well as cell therapy projects.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
hiPSC-derived cell models
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):